GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CXW · Sep 30, 2018

CoreCivic, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001564590-18-027228Reit
Operating-cash-flow growth88thOwn-history percentile · N=17
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

24.05% · OPTIONAL · VALID

Debt100thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.gross_debt

$1.8B · CORE · VALID

Net-income growth59thOwn-history percentile · N=17
Evidence method

Yoy · gp.fundamentals.net_income

-0.45% · CORE · VALID

Cash and equivalents100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$93.6M · CORE · VALID

Operating-income growth71thOwn-history percentile · N=17
Evidence method

Yoy · gp.fundamentals.operating_income

5.93% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History49 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Increased
Previous
-17.66%
Current
24.05%
Delta
41.71%
Debt Increased
Previous
$1.5B
Current
$1.8B
Delta
$271.0M
Earnings Growth Increased
Previous
-13.81%
Current
-0.45%
Delta
13.36%
Liquidity Increased
Previous
$71.4M
Current
$93.6M
Delta
$22.3M
Profitability Increased
Previous
-5.46%
Current
5.93%
Delta
11.39%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.